메뉴 건너뛰기




Volumn 106, Issue 2, 1997, Pages 149-160

Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry

Author keywords

32P postlabelling; Accelerator mass spectrometry; DNA binding; Tamoxifen; Toremifene

Indexed keywords

TAMOXIFEN; TOREMIFENE; DNA; GLOBIN;

EID: 0030613674     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00063-X     Document Type: Article
Times cited : (35)

References (28)
  • 2
    • 0028208456 scopus 로고
    • Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
    • NSABP Contributors, Fisher B., Costantino J.P., Redmond C.K., Fisher E.R., Wickerham D.L., Cronin W.M. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 86:1994;527-537.
    • (1994) J. Natl. Cancer Inst. , vol.86 , pp. 527-537
    • Nsabp Contributors1    Fisher, B.2    Costantino, J.P.3    Redmond, C.K.4    Fisher, E.R.5    Wickerham, D.L.6    Cronin, W.M.7
  • 3
    • 0027428568 scopus 로고
    • Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1:CD(BR) rats
    • Hard G.C., Iatropoulos M.J., Jordan K., Radi L., Kaltenberg O.P., Imondi A.R., Williams G.M. Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1:CD(BR) rats. Cancer Res. 53:1993;4534-4541.
    • (1993) Cancer Res. , vol.53 , pp. 4534-4541
    • Hard, G.C.1    Iatropoulos, M.J.2    Jordan, K.3    Radi, L.4    Kaltenberg, O.P.5    Imondi, A.R.6    Williams, G.M.7
  • 4
    • 0027201501 scopus 로고
    • Two-year carcinogenicity study of tamoxifen in Alderly Park Wistar-derived rats
    • Greaves P., Goonetilleke R., Nunn G., Topham J., Orton T. Two-year carcinogenicity study of tamoxifen in Alderly Park Wistar-derived rats. Cancer Res. 53:1993;3919-3924.
    • (1993) Cancer Res. , vol.53 , pp. 3919-3924
    • Greaves, P.1    Goonetilleke, R.2    Nunn, G.3    Topham, J.4    Orton, T.5
  • 5
  • 7
    • 0026319776 scopus 로고
    • Cytochrome P450 mediated action and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: Possible involvement of the flavin-containing monooxygenases in tamoxifen activation
    • Mani C., Kupfer D. Cytochrome P450 mediated action and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of the flavin-containing monooxygenases in tamoxifen activation. Cancer Res. 51:1991;6052-6058.
    • (1991) Cancer Res. , vol.51 , pp. 6052-6058
    • Mani, C.1    Kupfer, D.2
  • 9
    • 0030069966 scopus 로고    scopus 로고
    • Tamoxifen metabolic activation: Comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo
    • Moorthy B., Sriram P., Pathak D.N., Bodell W.J., Randerath K. Tamoxifen metabolic activation: Comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo. Cancer Res. 56:1996;53-57.
    • (1996) Cancer Res. , vol.56 , pp. 53-57
    • Moorthy, B.1    Sriram, P.2    Pathak, D.N.3    Bodell, W.J.4    Randerath, K.5
  • 11
    • 0028361529 scopus 로고
    • Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA
    • Felton J.S., Turteltaub K.W. Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA. Environ. Health Perspect. 102:1994;450-452.
    • (1994) Environ. Health Perspect. , vol.102 , pp. 450-452
    • Felton, J.S.1    Turteltaub, K.W.2
  • 14
    • 0028210878 scopus 로고
    • DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems
    • Pathak D.N., Bodell W.J. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems. Carcinogenesis. 15:1994;529-532.
    • (1994) Carcinogenesis , vol.15 , pp. 529-532
    • Pathak, D.N.1    Bodell, W.J.2
  • 15
    • 0027347175 scopus 로고
    • Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: A new technique for tracing isotope-labelled DNA adduction
    • IARC, Lyon
    • K.W. Turteltaub, J.S. Vogel, C.E. Frantz, F. Fultz, Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabeling Methods for Detection of DNA Adducts, IARC, Lyon, 1993, pp. 293-301.
    • (1993) Postlabeling Methods for Detection of DNA Adducts , pp. 293-301
    • Turteltaub, K.W.1    Vogel, J.S.2    Frantz, C.E.3    Fultz, F.4
  • 16
    • 0030050137 scopus 로고    scopus 로고
    • Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen
    • Osborne M.R., Hewer A., Hardcastle I.R., Carmichael P.L., Phillips D.H. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen. Cancer Res. 56:1996;66-71.
    • (1996) Cancer Res. , vol.56 , pp. 66-71
    • Osborne, M.R.1    Hewer, A.2    Hardcastle, I.R.3    Carmichael, P.L.4    Phillips, D.H.5
  • 17
    • 0022491941 scopus 로고
    • Modified Edman degredation applied to hemoglobin adducts by a modified Edman degredation method
    • Tornqvist M., Mowrer J., Jensen S., Ehrenberg L. Modified Edman degredation applied to hemoglobin adducts by a modified Edman degredation method. Anal. Biochem. 154:1986;255-266.
    • (1986) Anal. Biochem. , vol.154 , pp. 255-266
    • Tornqvist, M.1    Mowrer, J.2    Jensen, S.3    Ehrenberg, L.4
  • 18
    • 0026771023 scopus 로고
    • The detection of DNA adducts, DNA base changes and chromosome damage for the assessment of exposure to genotoxic pollutants
    • Jones N.J., Parry J.M. The detection of DNA adducts, DNA base changes and chromosome damage for the assessment of exposure to genotoxic pollutants. Aquat. Toxicol. 22:1992;323-343.
    • (1992) Aquat. Toxicol. , vol.22 , pp. 323-343
    • Jones, N.J.1    Parry, J.M.2
  • 19
    • 0028670421 scopus 로고
    • Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes
    • Mani C., Pearce R., Parkinson A., Kupfer D. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis. 15:1994;2715-2720.
    • (1994) Carcinogenesis , vol.15 , pp. 2715-2720
    • Mani, C.1    Pearce, R.2    Parkinson, A.3    Kupfer, D.4
  • 20
  • 21
    • 0028177045 scopus 로고
    • A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes
    • Lim C.K., Yuan Z., Lamb J.H., White I.N.H., De Matteis F., Smith L.L. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis. 15:1994;589-593.
    • (1994) Carcinogenesis , vol.15 , pp. 589-593
    • Lim, C.K.1    Yuan, Z.2    Lamb, J.H.3    White, I.N.H.4    De Matteis, F.5    Smith, L.L.6
  • 22
    • 0029866506 scopus 로고    scopus 로고
    • Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins
    • Dehal S.S., Kupfer D. Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins. Cancer Res. 56:1996;1283-1290.
    • (1996) Cancer Res. , vol.56 , pp. 1283-1290
    • Dehal, S.S.1    Kupfer, D.2
  • 23
    • 0028172242 scopus 로고
    • α-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA binding activity in rat hepatocytes
    • Phillips D.H., Carmichael P.L., Hewer A., Cole K.J., Poon G.K. α-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA binding activity in rat hepatocytes. Cancer Res. 54:1995;5518-5522.
    • (1995) Cancer Res. , vol.54 , pp. 5518-5522
    • Phillips, D.H.1    Carmichael, P.L.2    Hewer, A.3    Cole, K.J.4    Poon, G.K.5
  • 24
    • 0028979277 scopus 로고
    • DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro
    • Hemminki K., Widlak P., Hou S.M. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis. 16:1995;1661-1664.
    • (1995) Carcinogenesis , vol.16 , pp. 1661-1664
    • Hemminki, K.1    Widlak, P.2    Hou, S.M.3
  • 27
    • 0029815539 scopus 로고    scopus 로고
    • Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: Comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen
    • Pathak D.N., Pongracz K., Bodell W.J. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: Comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen. Carcinogenesis. 17:1996;1785-1790.
    • (1996) Carcinogenesis , vol.17 , pp. 1785-1790
    • Pathak, D.N.1    Pongracz, K.2    Bodell, W.J.3
  • 28
    • 0029745072 scopus 로고    scopus 로고
    • Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients
    • Hemminki K., Rajaniemi H., Lindahl B., Moberger B. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res. 56:1996;4374-4377.
    • (1996) Cancer Res. , vol.56 , pp. 4374-4377
    • Hemminki, K.1    Rajaniemi, H.2    Lindahl, B.3    Moberger, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.